Neuroone Medical Technologies Corp (NMTC) Financials

$1.67

$0.06 (3.73%)

As on 02-Sep-2026 16:15EDT

Market cap

$16 Mln

Revenue (TTM)

$10 Mln

P/E Ratio

--

P/B Ratio

4.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Operating Revenue	10.00	12.10	3.45	1.95	0.17	0.18
Cost of Revenue	4.43	3.96	2.37	1.50	0.24	0.28
Gross Profit	5.57	8.14	1.08	0.46	-0.07	-0.10
Operating Expenses	13.17	12.37	12.97	12.41	9.96	10.12
Operating Profit (EBIT)	-7.60	-4.23	-11.89	-11.96	-10.03	-10.22
Other Income	--	--	--	--	--	--
Profit before Tax	-7.15	-3.61	-12.32	-11.86	-10.00	-9.95
Provision for Tax	--	--	--	0.03	-0.11	0.27
Profit after Tax (Net Income)	-7.15	-3.61	-12.32	-11.86	-10.00	-9.95
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-10.00	-9.95

Liabilities ($ Mln)	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Shareholder's Funds	3.77	7.07	0.82	6.25	9.60	6.55
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.38	1.41	2.33	0.06	0.12	0.20
Current Liabilities	2.04	2.30	2.21	1.79	3.10	1.18
Total Liabilities	8.23	10.79	5.37	8.10	12.82	7.94

Assets ($ Mln)	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Non-Current Assets	0.40	0.56	0.74	0.78	0.65	0.65
Current Assets	5.79	10.23	4.63	7.31	12.18	7.29
Total Assets	11.97	10.79	5.37	8.10	12.82	7.94
Total Debt*	0.07	0.27	0.26	0.18	0.20	0.32
Net Current Assets	--	7.92	2.42	5.52	9.08	6.11

Cashflow ($ Mln)	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Cash From Operating Activities	--	-2.84	-11.01	-12.89	-7.52	-8.60
Cash Flow from Investing Activities	--	-0.08	-0.12	2.65	-3.24	-0.07
Cash from Financing Activities	--	8.03	7.27	7.40	12.02	11.53
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Adjusted EPS ($)	-0.89	-0.54	-2.76	-3.03	-3.70	-4.97
Cash EPS ($)	--	-0.50	-2.71	-2.97	-3.66	-4.93
Adjusted Book Value ($)	--	1.06	0.18	1.59	3.55	3.27
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.42	-2.47	-3.29	-2.78	-4.30
Free Cash Flow per Share ($)	--	-0.44	-2.50	-3.39	-2.88	-4.33

Profitability Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
ROCE (%)	--	-85.62	-327.78	-146.04	-119.92	-194.01
ROE (%)	-140.60	-91.34	-348.39	-149.61	-123.77	-230.81
ROA (%)	-59.03	-44.63	-182.93	-113.38	-96.33	-156.69
EBIT Margin (%)	-71.51	-27.04	-350.10	-607.42	-5,841.95	-5,582.56
Net Margin (%)	-71.51	-29.80	-356.74	-607.42	-5,841.95	-5,584.28
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Revenue Growth (%)	50.82	2.50	0.77	10.41	-0.04	-0.91
EBIT Growth (%)	-53.06	72.94	-1.94	-18.60	-0.55	-101.92
Net Profit Growth (%)	-33.96	70.73	-3.87	-18.60	-0.52	27.07
EPS Growth (%)	13.69	0.80	0.09	0.18	0.26	0.57
Book Value Growth (%)	-57.29	--	--	--	--	--

Valuation Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Price / Earnings	--	-1.65	-0.36	-0.29	-0.46	-0.79
Price / Book Value	4.79	0.84	5.37	0.56	0.48	1.21
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-2.10	0.12	-0.27	0.14	0.64	-0.13
Close Price ($)	3.04	5.33	5.94	5.34	10.14	23.70
High Price ($)	6.96	8.34	12.00	17.22	25.50	81.00
Low Price ($)	2.89	2.37	3.61	4.80	3.06	14.94
Market Cap ($ Cr)	16.12	--	--	--	--	--

Solvency Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Debt to Equity	--	0.04	0.32	0.03	0.02	0.05
Short term debt to equity ratio	--	0.02	0.08	0.02	0.01	0.02
Current Ratio	2.84	4.44	2.09	4.08	3.93	6.17
Quick Ratio	1.71	3.47	0.90	3.12	3.70	6.09
Interest Coverage	-20.40	-9.79	-52.79	--	-320.99	-3,257.49

Operating Efficiency Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Debtors to sales (%)	10.99	10.45	5.12	--	19.42	27.13
Asset Turnover	0.83	1.50	0.51	0.19	0.02	0.03
Receivable days	--	21.76	9.34	3.11	87.03	49.55
Inventory Days	--	224.43	335.64	296.81	605.94	65.06
Payable days	--	94.15	131.91	196.89	1,099.31	854.80
Cash Conversion Cycle	--	152.04	213.07	103.03	-406.33	-740.19

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.